Exemestane and aromatase inhibitors in the management of advanced breast cancer

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.2, 2004-02, pp. : 307-316

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A review of exemestane in the management of breast cancer

By Wong Nan Soon Pritchard Kathleen I

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 13, 2005-10 ,pp. : 2353-2363

Informa Healthcare

Access to resources Recommend Favorite

Aromatase inhibitors and breast cancer prevention

By Litton Jennifer Keating Arun Banu K Brown Powel H Hortobagyi Gabriel N

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 3, 2012-02 ,pp. : 325-331

Informa Healthcare

Access to resources Recommend Favorite

Experience with Exemestane in the Treatment of Early and Advanced Breast Cancer

By Lønning Per Eystein Geisler Jürgen

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 7, 2008-07 ,pp. : 987-997

Informa Healthcare

Access to resources Recommend Favorite

Fulvestrant as EFECTive as exemestane in advanced breast cancer

Inpharma, Vol. 1, Iss. 1570, 2007-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Aromatase Inhibitors and Inactivators for Breast Cancer Therapy

By Lønning P.E.

Drugs & Aging, Vol. 19, Iss. 4, 2002-04 ,pp. : 277-298

Adis International

Access to resources Recommend Favorite